Japanese Encephalitis

Japanese encephalitis is a serious viral brain infection transmitted through the bite of infected mosquitoes.  It is the leading cause of viral encephalitis in Asia, and while the overall risk to most short-term travellers is low, for those spending extended time in rural or agricultural areas across the region it represents a meaningful and potentially devastating health risk.  There is no specific treatment for Japanese encephalitis once infection occurs, making vaccination the only reliable way to protect yourself before you travel.

At Jasins Pharmacy in Hounslow, our experienced travel health team can assess whether the Japanese encephalitis vaccine is appropriate for your trip and administer the course quickly and conveniently before your departure — no GP referral required.

 

Book now

 

 

How Japanese Encephalitis is Transmitted

Japanese encephalitis is caused by the Japanese encephalitis virus (JEV), a flavivirus belonging to the same family as dengue, Zika, and West Nile virus.  It is transmitted to humans through the bite of infected Culex mosquitoes, which breed predominantly in rice paddies, marshes, and other standing water associated with agricultural land.  Unlike some mosquito-borne diseases, Japanese encephalitis cannot be spread directly from person to person.

The virus circulates in a cycle involving:

• Wading birds and pigs, which act as amplifying hosts for the virus and are the primary reservoir in nature
• Culex tritaeniorhynchus mosquitoes, which feed on infected animals and then transmit the virus to humans
• Rural and peri-urban environments where rice cultivation, pig farming, and standing water are prevalent

 

Transmission is strongly seasonal in temperate regions, peaking during and after the monsoon season when mosquito populations are at their highest.  In tropical parts of Southeast Asia, transmission can occur year-round.  Travellers who spend time outdoors in rural areas — particularly at dusk and during the night when Culex mosquitoes are most active — face the greatest risk of exposure.

 

Symptoms of Japanese Encephalitis

The vast majority of people infected with the Japanese encephalitis virus — around 99% — experience no symptoms at all or only a mild, non-specific febrile illness.  However, for the small proportion who go on to develop encephalitis (inflammation of the brain), the consequences can be severe and life-altering.  Symptoms of encephalitis typically appear between five and fifteen days after a mosquito bite from an infected insect.

Early symptoms include:

• Sudden onset of high fever
• Severe headache
• Neck stiffness
• Nausea and vomiting
• General disorientation and confusion

 

As the infection progresses, more serious neurological symptoms may develop, including:

• Seizures, particularly in children
• Tremors and movement disorders
• Paralysis of limbs or facial muscles
• Loss of consciousness and coma

 

Of those who develop encephalitis, approximately 20 to 30% do not survive.  Among those who recover, up to 30 to 50% are left with permanent neurological or psychiatric complications, including cognitive impairment, behavioural changes, and movement disorders.  The severity of these outcomes makes pre-travel vaccination a particularly important consideration for anyone heading to an affected region.

 

The Japanese Encephalitis Vaccine

The Japanese encephalitis vaccine available in the UK is Ixiaro, an inactivated vaccine that is highly safe and well tolerated.  It works by stimulating the immune system to produce protective antibodies against the Japanese encephalitis virus before any potential exposure occurs.

• Standard course — two doses given on days 0 and 28; both doses should be completed at least one week before potential exposure to allow full immunity to develop
• Accelerated schedule — for adults aged 18 to 65 who have limited time before travel, an accelerated schedule of two doses given on days 0 and 7 is available
• Timing — begin the vaccine course at least four weeks before departure where possible to allow the standard schedule to be completed comfortably
• Booster doses — a single booster dose is recommended twelve to twenty-four months after the primary course for those who remain at risk; the booster extends protection for up to three years
• Suitability — Ixiaro is licensed for adults and children aged two months and over; speak to our pharmacist about appropriate dosing for infants and young children

 

It is worth noting that, unlike rabies, Japanese encephalitis does not have an effective post-exposure treatment — making pre-travel vaccination the only practical means of protection.  Once you have been bitten by an infected mosquito and symptoms develop, there is no specific medical intervention that can alter the course of the illness.

 

Who Should Consider the Japanese Encephalitis Vaccine?

The Japanese encephalitis vaccine is not recommended for all travellers to Asia, but for a significant proportion it represents a vital layer of protection.  Whether vaccination is appropriate depends on your destination, the duration of your stay, the time of year, and the activities you have planned.

Vaccination is particularly recommended for:

• Travellers spending a month or more in rural or agricultural areas of endemic countries, particularly during or after the monsoon season
• Shorter-stay travellers who plan to spend substantial time outdoors in rural environments, such as those involved in cycling, camping, trekking, or fieldwork
• Those travelling to regions experiencing active Japanese encephalitis outbreaks, regardless of trip duration
• Expatriates, aid workers, researchers, and long-term visitors living or working in endemic rural areas
• Children travelling with families to high-risk areas, as they tend to spend more time outdoors and may be less consistent with insect bite precautions

 

Countries where Japanese encephalitis is endemic include India, Nepal, China, Japan, South Korea, Thailand, Vietnam, Cambodia, Indonesia, the Philippines, and parts of Australia.  Our pharmacists at Jasins Pharmacy in Hounslow will review your itinerary in detail and advise on whether vaccination is appropriate for your specific travel plans.

 

Possible Side Effects

The Ixiaro Japanese encephalitis vaccine has an excellent safety record and is well tolerated by the vast majority of people who receive it.  Side effects, where they occur, are generally mild and short-lived.

Possible side effects include:

• Soreness, tenderness, or mild swelling at the injection site
• Headache
• Muscle aches
• Fatigue
• Mild fever
• Nausea

 

These effects typically resolve within two to three days and do not usually require any treatment.  Serious adverse reactions to Ixiaro are rare.  As with any vaccination, if you have a history of allergies, are pregnant, or are taking regular medications, please inform our pharmacist before your appointment so that any relevant factors can be considered before proceeding.

 

Frequently Asked Questions

 

What is Japanese encephalitis?

Japanese encephalitis is a serious viral infection of the brain caused by the Japanese encephalitis virus, transmitted through the bite of infected Culex mosquitoes in rural and agricultural areas across Asia.  While most infections cause no symptoms or only mild illness, a small proportion develop severe encephalitis, which can be fatal or lead to permanent neurological damage.

 

Which countries carry a risk of Japanese encephalitis?

Japanese encephalitis is endemic across much of Asia, including India, Nepal, China, Japan, South Korea, Thailand, Vietnam, Cambodia, Indonesia, the Philippines, and parts of northern Australia.  The risk is highest in rural and agricultural areas, particularly during and after the monsoon season, and your pharmacist will advise on the specific risk for your destination and travel period.

 

How many doses does the Japanese encephalitis vaccine require?

The standard course of the Ixiaro vaccine consists of two doses given on days 0 and 28, with both doses ideally completed at least one week before entering a risk area.  An accelerated schedule of two doses on days 0 and 7 is available for adults aged 18 to 65 who have limited time before their departure date.

 

Is Japanese encephalitis only a risk in rural areas?

The risk is highest in rural and agricultural settings, particularly near rice paddies, marshes, and pig farms where the mosquito vectors breed and the amplifying animal hosts are present.  However, urban travellers who spend time in peri-urban green spaces or travel to rural areas even briefly during high-risk periods should also discuss their individual risk with a pharmacist.

 

Can I still get Japanese encephalitis if I have been vaccinated?

The Ixiaro vaccine is highly effective and provides strong protection against Japanese encephalitis following the completion of the full course.  However, no vaccine is 100% effective, which is why combining vaccination with consistent insect bite avoidance measures — such as using DEET repellent, wearing long-sleeved clothing, and sleeping under a mosquito net — is always recommended.

 

Are there side effects from the Japanese encephalitis vaccine?

The Ixiaro vaccine is generally very well tolerated, and the majority of people experience no significant side effects.  Where mild reactions do occur — such as soreness at the injection site, headache, or brief fatigue — they typically resolve within a few days without any treatment.

 

Travel to Asia with Confidence

If you are planning a trip to rural or agricultural areas of Asia, getting the right travel health advice before you go could make a profound difference to your safety.  Book a consultation at Jasins Pharmacy in Hounslow today and let our experienced team ensure you are fully protected before you travel.